Avantor (AVTR) Set to Announce Earnings on Friday

Avantor (NYSE:AVTR) is scheduled to release its earnings data before the market opens on Friday, April 26th. Analysts expect Avantor to post earnings of $0.20 per share for the quarter. Avantor has set its FY 2024 guidance at 0.960-1.040 EPS.Persons that wish to register for the company’s earnings conference call can do so using this link.

Avantor (NYSE:AVTR) last posted its quarterly earnings data on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.03. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The firm had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.70 billion. During the same period last year, the company posted $0.32 EPS. The business’s quarterly revenue was down 4.0% on a year-over-year basis. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Avantor Stock Performance

AVTR stock opened at $25.66 on Wednesday. The stock has a 50-day moving average price of $25.03 and a 200-day moving average price of $22.55. Avantor has a 1-year low of $16.63 and a 1-year high of $26.16. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 1.00. The firm has a market cap of $17.40 billion, a PE ratio of 53.45, a price-to-earnings-growth ratio of 2.45 and a beta of 1.37.

Analyst Ratings Changes

AVTR has been the subject of several research reports. JPMorgan Chase & Co. raised their target price on Avantor from $26.00 to $29.00 and gave the company an “overweight” rating in a research note on Thursday, February 15th. Citigroup raised their target price on Avantor from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Thursday, February 15th. UBS Group raised their target price on Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research note on Thursday, February 15th. Robert W. Baird lifted their price target on Avantor from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Thursday, February 15th. Finally, Barclays lifted their price target on Avantor from $27.00 to $30.00 and gave the company an “overweight” rating in a research note on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.71.

Insiders Place Their Bets

In other Avantor news, EVP James Bramwell sold 6,203 shares of Avantor stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total transaction of $151,911.47. Following the transaction, the executive vice president now owns 101,143 shares of the company’s stock, valued at approximately $2,476,992.07. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 1.30% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.